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Introduction
Today although most of consumed drugs are synthetic, but 
it has been estimated that at least one third of all medicinal 
products have plant origin or have been transformed 
after they are extracted from the plants. Using medicinal 
plants for diseases has an old history (1). Medicinal plants 
have less side effects and risks compared to chemical 
drugs due to having natural origin and also contiguity 
and compatibility with the human body physiology. This 
property is one of the main reasons of returned approach 
and tendency of people toward medicinal plants and 
using it compared to chemical drugs (1,2). Therefore, 
pharmaceutical industries and research groups in many 
countries have focused their attention on cultivating and 
producing medicinal plants (2). Citronella or Indian nard 
(with the scientific name of Valeriana sisymbriifolium 
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Implication for health policy/practice/research/medical education:
The essence prepared from Nardostachys Jatamansi plant in Iran seems to be different in terms of some compounds and components. 
So it is necessary to identify and register quality and quantity characteristics of compounds available in this plat in the Iranian 
medicinal plants pharmacopeia.
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Introduction: With regard to using drugs with plant origin and with the aim of suitable use of 
these types of drugs and preventing them to be abused, it is necessary to determine the standards 
of these plants. The aim of the present study was to identify and study chemical compounds of 
Nardostachys Jatamansi essence in Iran and define monograph of this plant for the Iranian plant 
pharmacopeia.  
Methods: In an experimental study the Nardostachys Jatamansi specimen was prepared from 
the market in Iran. The essence of the plant was prepared by the hydro-distillation in Clevenger 
apparatus. Essence was obtained as a greenish yellow oil layer with the 0.07 % yield. The essence 
compounds were identified quantitatively by Gas Chromatography-Mass Spectroscopy (GC/MS) 
method. 
Results: Totally, 29 compounds were identified in Nardostachys Jatamansi essence.  The retention 
indexes (RI) were only similar with overall standard values in two compounds like mesitylene and 
P-cymene. In this line the RI values about three compounds of valerenic acid, palmitic acid, and 
valerenyl isovalerate were determined significantly higher than standard values of RI. 
Conclusion: The essence prepared from the Nardostachys Jatamansi plant in Iran was different in 
terms of some compounds and components including valerenic acid, palmitic acid, and valerenyl 
isovalerate and so it is necessary to identify and register quality and quantity characteristics of 
compounds available in this plat in the Iranian medicinal plants pharmacopeia. 
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from Valerianaceae family) is a plant that its height 
reaches to 10-60 cm and mainly grows in summer. This 
plant has been used as an herbal medicine from the sixteen 
century (3). It has been used traditionally in different 
regions of Europe and Asia and today it is accepted as 
a medicinal plant with various benefits even in North 
America (4). Accordingly, the Valeriana sisymbriifolia 
has been paid attention by experts in pharmacology and 
also in the traditional and plant medicine and is used as a 
medicinal or food complement (5). According to clinical 
observations, the extract prepared from root of this plant 
has sedative property and so it is used as an anti-anxiety 
drug (6-8). Due to the antioxidant property of the extract 
of this plant, its inhibitive effects on the brain ischemia 
in animal models of study have been confirmed (9). 
Also antibacterial effects of this plant in preventing and 
treating infectious diseases have been proved (10). With 
regard to the fact that it is economical to use a medicinal 
plant with high effective materials in pharmaceutical 
industries, identification of chemical compounds present 
in plants essence and their effect is very important (11). 
It is fundamentally possible to understand the drug effect 
and also to determine effective mechanisms of the plant 
extract based on identifying compounds and components 
of the plant extract. Some main extract components 
of the plant root of Valeriana sisymbriifolium include: 
alkaloids (actinidin, creatinine, valerianine, and valerine), 
isovaleramide, gamma amino butiric asid (GABA), 
isovaleric acid, iridoids (isovaltrate).
In the present study the aim was to identify quality and 
quantity of chemicals in the plant essence of Iran. 
Materials and Methods
In a experimental study, Valeriana sisymbriifolia specimen 
was prepared from the Iran market. The dried plant was 
grinded by the crusher device. Then the essence was 
collected by the Hydro-distillation method in a Clevenger 
apparatus for 3 hours. Essence weight ratio of the plant 
was measured to be 0.07 w/w. The essence was maintained 
in colored glasses with closed lid in the refrigerator. 
Compounds available in the essence were determined 
by the a Gas chromatography device connected to the 
GC/MS (Hewlett, Packard 5792A, USA), with the ion-
trap system, column with the length of 60 m and the 
diameter of 0.25 mm that the static phase thickness was 
0.25 micrometer. The column temperature was set at 60 
to 280 oC with gradient of 4 ºC per minute, the injection 
chamber temperature of 280 oC and the ion resource 
temperature of 250 oC. The helium gas with the purity 
degree of 99/999, with gas speed of 2 ml/min and the PSI 
pressure of 17.7 and Electron ionization energy of 70 eV 
were used. 
Results
The greenish yellow essence with the 0.07% yield in terms 
of the weight (w/w) was obtained from this plant. Totally 
29 compounds were extracted in evaluating different 
components of the Valeriana sisymbriifolia extract that 
retention time values of these compounds were variable 
between 4.96 related to mesitylene and 34.32 related to 
valerenyl isovalerate. In result of comparing the RI of each 
of the Valeriana sisymbriifolia essence components in Iran 
with standard cases (Table 1), It was determined in this 
study that the RI values were similar to world standard 
values in only two compounds including mesitylene and 
p-cymene. In this line, the RI values were a little higher 
from standard values about some compounds including 
n-octanol, linalool, naphthalene, α-terpineole, cuminal, 
carvone, trans-anethole, thymole, carvacrol and valerenal 
in the compound presented in our study. However, 
the RI value was determined significantly higher than 
the standard values of RI about some compounds like 
valerenic acid, palmitic acid and valerenyl isovalerate. 
Discussion
In evaluating compounds of the Valeriana sisymbriifolia 
essence and materials by the GC/MS method the 
index of retention time is used. However, this index is 
potentially affected by other variables and conditions like 
temperature, chromatography column length and the 
column diameter, so other index named retention index 
or RI was used. In this study based on determining the RI 
index about each component of Valeriana sisymbriifolia 
and comparing it with standard RI values we found that 
the main difference between compounds presented in our 
study and cases mentioned in standard pharmacopeias 
was mainly in three compounds of valerenic acid, palmitic 
acid and valerenyl isovalerate that RI related to each three 
cases was determined significantly higher than standard 
values. In other words, Valeriana sisymbriifolia specimens 
in Iran can be differentiated from other specimens in 
other countries in terms of values of the above three 
compounds.
Valerenic acid has been identified as GABA-A receptor 
agonist that plays an important role as a sedative. Also, 
its role as an anti-inflammation is also proposed (14,15). 
About palmitic acid also recent researches have suggested 
sedative effects of this fatty acid and also its effect on 
modulating glucose metabolism (16). Based on above 
findings and with regard to obvious differences in above 
compounds between Iranian specimens and standard in 
the Valeriana sisymbriifolia essence, the therapeutic effects 
of this essence in Iranian specimens can be different from 
specimens in other points and so it is necessary to add 
mentioned characteristics in pharmacopeia of Iranian 
medicinal plants. Totally, it can be concluded that the 
essence prepared from the Valeriana sisymbriifolia plant in 
Iran is different in terms of  amount of some compounds 
like valerenic acid, palmitic acid and valerenyl isovalerate 
and with regard to clinical effects of these components 
specially sedative effects, anti-inflammation and also its 
effects in regulating the glucose metabolism, it is necessary 
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to identify and register qualitative and quantitative 
properties of Valeriana sisymbriifolia components in 
Iranian medicinal plant pharmacopeia. 
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